Cytodyn Inc Financials

CYDY

Export CSV

Key Financial Metrics

Revenue

N/A

EBITDA

$9.7M

YoY+153.7%

Cytodyn Inc's EBITDA was $9.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 153.7% from the prior year.

Free Cash Flow

N/A

Net Income

$3.7M

YoY+107.5%

Cytodyn Inc reported $3.7M in net income in fiscal year 2025. This represents an increase of 107.5% from the prior year.

EPS (Diluted)

$0.00

YoY+100.0%

Cytodyn Inc earned $0.00 per diluted share in fiscal year 2025. This represents an increase of 100.0% from the prior year.

Cash & Debt

$11.9M

YoY+282.7%

5Y CAGR-3.6%

10Y CAGR+27.5%

Cytodyn Inc held $11.9M in cash against $45.4M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

1.25B

YoY+18.0%

5Y CAGR+19.2%

10Y CAGR+34.7%

Cytodyn Inc had 1.25B shares outstanding in fiscal year 2025. This represents an increase of 18.0% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CYDY Income Statement

Metric	FY25	FY25	FY23	FY23	FY22	FY22
Revenue	N/A	N/A	$0-100.0%	$266K	$0	N/A
Cost of Revenue	N/A	N/A	N/A	$53K	N/A	N/A
Gross Profit	N/A	N/A	N/A	$213K	N/A	N/A
R&D Expenses	N/A	$7.2M+175.1%	$2.6M-90.3%	$27.0M-49.4%	$53.4M+1.4%	$52.6M
SG&A Expenses	$7.3M-32.9%	$10.8M-36.9%	$17.1M-61.3%	$44.3M+29.1%	$34.3M+71.8%	$20.0M
Operating Income	$9.7M+153.5%	-$18.1M+55.5%	-$40.6M+72.1%	-$145.4M-39.0%	-$104.6M-40.1%	-$74.6M
Interest Expense	N/A	$31.8M-19.0%	$39.2M-40.0%	$65.4M-9.0%	$71.9M+10.1%	$65.3M
Income Tax	$0	$0	$0	$0	$0	$0
Net Income	$3.7M+107.5%	-$49.8M+37.6%	-$79.8M+62.1%	-$210.8M-19.5%	-$176.5M-26.1%	-$139.9M
EPS (Diluted)	$0.00+100.0%	$-0.05+50.0%	$-0.10+67.7%	$-0.31-3.3%	$-0.30+9.1%	$-0.33

Metric	Q2'26	Q2'26	Q2'26	Q3'25	Q2'26	Q2'26	Q2'25	Q3'25
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$650K
SG&A Expenses	$1.8M+5.0%	$1.7M	N/A	$1.5M-34.2%	$2.3M+42.8%	$1.6M	N/A	$2.8M
Operating Income	-$21.7M-338.6%	-$4.9M	N/A	-$4.0M-8.0%	-$3.7M-116.5%	$22.4M	N/A	-$3.4M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$8.5M
Income Tax	$0	$0	N/A	$0	$0	$0	N/A	$0
Net Income	-$22.6M-308.1%	-$5.5M	N/A	-$4.8M+0.2%	-$4.8M-124.8%	$19.2M	N/A	-$11.9M
EPS (Diluted)	$-0.02	$0.00	N/A	$0.00	$0.00-100.0%	$0.02	N/A	$-0.01

CYDY Balance Sheet

Metric	FY25	FY25	FY23	FY23	FY22	FY22
Total Assets	$18.0M+62.1%	$11.1M-1.4%	$11.3M-61.3%	$29.2M-77.9%	$132.1M+161.5%	$50.5M
Current Assets	$17.9M+65.3%	$10.8M+0.1%	$10.8M+2.8%	$10.5M-70.9%	$36.1M-2.0%	$36.8M
Cash & Equivalents	$11.9M+282.7%	$3.1M+22.4%	$2.5M-39.9%	$4.2M-87.5%	$33.9M+137.7%	$14.3M
Inventory	N/A	$0	$0	N/A	$93.5M+388.2%	$19.1M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$114.1M-10.8%	$127.9M+5.9%	$120.8M-2.3%	$123.6M-19.3%	$153.1M+188.9%	$53.0M
Current Liabilities	$70.5M-16.2%	$84.2M-29.7%	$119.8M-2.7%	$123.2M-19.3%	$152.5M+242.8%	$44.5M
Long-Term Debt	$45.4M+0.7%	$45.0M-1.6%	$45.7M+8.3%	$42.2M0.0%	$42.2M	N/A
Total Equity	-$96.0M+17.7%	-$116.8M-6.6%	-$109.5M-16.0%	-$94.4M-349.1%	-$21.0M-747.2%	-$2.5M
Retained Earnings	-$887.8M+0.4%	-$891.5M-5.9%	-$841.7M-9.9%	-$766.1M-38.4%	-$553.7M-47.5%	-$375.3M

Metric	Q2'26	Q2'26	Q2'26	Q3'25	Q2'26	Q2'26	Q2'25	Q3'25
Total Assets	$8.9M-33.7%	$13.5M-25.3%	$18.0M-14.8%	$21.2M-14.8%	$24.9M-11.2%	$28.0M+151.6%	$11.1M+8.4%	$10.3M
Current Assets	$8.8M-33.8%	$13.3M-25.3%	$17.9M-14.8%	$21.0M-14.8%	$24.6M-11.2%	$27.7M+156.5%	$10.8M+9.1%	$9.9M
Cash & Equivalents	$5.0M-46.6%	$9.3M-21.6%	$11.9M-27.4%	$16.4M-23.1%	$21.3M-14.4%	$24.9M+701.3%	$3.1M+121.5%	$1.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	$0	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$128.7M+13.9%	$113.0M-1.0%	$114.1M-0.1%	$114.2M-0.1%	$114.3M+0.9%	$113.2M-11.5%	$127.9M-1.4%	$129.7M
Current Liabilities	$85.1M+22.6%	$69.4M-1.6%	$70.5M-0.1%	$70.6M-0.1%	$70.6M+1.5%	$69.6M-17.4%	$84.2M-35.0%	$129.5M
Long-Term Debt	$42.2M-3.7%	$43.8M-3.5%	$45.4M-1.1%	$45.8M-0.5%	$46.1M+1.7%	$45.3M+0.6%	$45.0M+1.7%	$44.2M
Total Equity	-$119.7M-20.3%	-$99.5M-3.6%	-$96.0M-3.3%	-$93.0M-4.0%	-$89.4M-4.9%	-$85.2M+27.0%	-$116.8M+2.2%	-$119.4M
Retained Earnings	-$915.9M-2.5%	-$893.3M-0.6%	-$887.8M-0.7%	-$881.8M-0.5%	-$877.1M-0.5%	-$872.3M+2.2%	-$891.5M-1.9%	-$874.7M

CYDY Cash Flow Statement

Metric	FY25	FY25	FY23	FY23	FY22	FY22
Operating Cash Flow	-$8.8M+20.2%	-$11.0M+56.3%	-$25.1M+67.7%	-$77.7M+33.9%	-$117.6M-70.9%	-$68.8M
Capital Expenditures	N/A	N/A	N/A	N/A	$122K+197.6%	$41K
Free Cash Flow	N/A	N/A	N/A	N/A	-$117.7M-71.0%	-$68.8M
Investing Cash Flow	N/A	N/A	N/A	N/A	-$122K-197.6%	-$41K
Financing Cash Flow	$10.9M-7.6%	$11.7M-60.7%	$29.9M-37.7%	$48.0M-65.0%	$137.3M+72.4%	$79.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q2'26	Q2'26	Q3'25	Q2'26	Q2'26	Q2'25	Q3'25
Operating Cash Flow	N/A	-$2.5M	N/A	N/A	N/A	$5.4M	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	-$121K	N/A	N/A	N/A	$9.7M	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CYDY Financial Ratios

Metric	FY25	FY25	FY23	FY23	FY22	FY22
Gross Margin	N/A	N/A	N/A	80.1%	N/A	N/A
Operating Margin	N/A	N/A	N/A	-54663.2%	N/A	N/A
Net Margin	N/A	N/A	N/A	-79255.6%	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	20.8%+468.3pp	-447.6%+259.3pp	-706.9%+15.5pp	-722.4%-588.8pp	-133.6%+143.4pp	-277.0%
Current Ratio	0.25+0.1	0.13+0.0	0.090.0	0.09-0.2	0.24-0.6	0.83
Debt-to-Equity	-0.47-0.1	-0.39+0.0	-0.42+0.0	-0.45+1.6	-2.01+19.4	-21.36
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q2'26	Q2'26	Q3'25	Q2'26	Q2'26	Q2'25	Q3'25
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-253.0%-211.9pp	-41.1%	N/A	-22.4%-3.3pp	-19.2%-87.8pp	68.6%	N/A	-116.1%
Current Ratio	0.10-0.1	0.19-0.1	0.25-0.0	0.30-0.1	0.35-0.0	0.40+0.3	0.13+0.1	0.08
Debt-to-Equity	-0.35+0.1	-0.44+0.0	-0.47+0.0	-0.49+0.0	-0.52+0.0	-0.53-0.1	-0.39-0.0	-0.37
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

Is Cytodyn Inc profitable?

Yes, Cytodyn Inc (CYDY) reported a net income of $3.7M in fiscal year 2025.

What is Cytodyn Inc's earnings per share (EPS)?

Cytodyn Inc (CYDY) reported diluted earnings per share of $0.00 for fiscal year 2025.

What is Cytodyn Inc's EBITDA?

Cytodyn Inc (CYDY) had EBITDA of $9.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cytodyn Inc have?

As of fiscal year 2025, Cytodyn Inc (CYDY) had $11.9M in cash and equivalents against $45.4M in long-term debt.

What is Cytodyn Inc's operating cash flow?

Cytodyn Inc (CYDY) generated -$8.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cytodyn Inc's total assets?

Cytodyn Inc (CYDY) had $18.0M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Cytodyn Inc have outstanding?

Cytodyn Inc (CYDY) had 1.25B shares outstanding as of fiscal year 2025.

What is Cytodyn Inc's current ratio?

Cytodyn Inc (CYDY) had a current ratio of 0.25 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Cytodyn Inc's debt-to-equity ratio?

Cytodyn Inc (CYDY) had a debt-to-equity ratio of -0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cytodyn Inc's return on assets (ROA)?

Cytodyn Inc (CYDY) had a return on assets of 20.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.